CERS Q4 2024 Earnings — Cerus Corporation Revenue & Financial Results | Market Cap Arena

CERSCerus Corporation

$358M

Q4 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$51M+8.6% YoY

Gross Profit

$27M53.9% margin

Operating Income

-$1M-2.9% margin

Net Income

-$3M-5.0% margin

EPS (Diluted)

$-0.01

QoQ Revenue Growth

+10.4%

Cash Flow

Operating Cash Flow

$5M

Free Cash Flow

$4M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$201M

Total Liabilities

$144M

Stockholders' Equity

$56M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$51M	$47M	+8.6%
Gross Profit	$27M	$26M	+5.5%
Operating Income	-$1M	$976,000	-248.5%
Net Income	-$3M	-$1M	-89.8%

Revenue Segments

Product

$51M90%

Government Contract

$6M10%